|
Point of Care Diagnostics to Chip in 34% in Global IVD Market
The leading market research firm RNCOS has launched its new report, "Global In Vitro Diagnostic Market Analysis", that anticipates the worldwide In Vitro Diagnostic (IVD) market to hit the total revenues of about US$ 53 Billion by 2012. Out of this, Point of Care Diagnostics (POCT) currently makes up for the largest share in the global IVD market and is projected to maintain its share during the forecasted period.
advertisement
POCT is real-time diagnostic testing which is performed near to or at the patient's site with the result may leading to a change in the patient's treatment.
According to the RNCOS research, POCT is one of the fastest growing and biggest segments of the IVD market. The segment accounted for around 33.4% of the total market in 2007. The POCT segment is forecasted to gain more popularity in future due to the multitude of benefits its offers, including faster results, availability of new computer systems and biosensor technologies, rising adoption of self-testing products, and improving demand for more efficient testing methods by physicians.
As a result, revenues from the POCT market are forecasted to register CAGR growth of nearly 6.9%, higher than the overall market's growth (in CAGR terms) of around 6.7%. Blood glucose testing, which contributed 70% share in the POCT market, is likely to remain the largest segment in future, while cardiac markers with 3% share are expected to emerge as the fastest growing one.
"Global In Vitro Diagnostic Market Analysis" provides comprehensive and detailed overview on the global IVD market with thorough analysis on traditional IVD market, new emerging technologies, market size, growth, share, geographical distribution, segmentation, grow th factors, trends and challenges for the development of the market. The report also gives forecast on regional IVD market, segment-wise (clinical segment) IVD market, like molecular diagnostics, immune chemistry, clinical chemistry, microbiology and blood screen immunoassays.
About RNCOS E-Services Pvt Ltd.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit:
http://rncos.com/Report/IM103.htm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
|
